Mace L Rothenberg Selected Research

Mace L Rothenberg Research Topics

Disease

37	Neoplasms (Cancer) 12/2018 - 09/2002
17	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2002
6	Ovarian Neoplasms (Ovarian Cancer) 06/2011 - 10/2002
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
4	Neutropenia 02/2012 - 12/2002
3	Nausea 02/2012 - 12/2002
3	Diarrhea 02/2012 - 12/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2009 - 05/2003
3	Fatigue 08/2008 - 04/2003
2	Colonic Neoplasms (Colon Cancer) 06/2012 - 05/2008
2	Ovarian Epithelial Carcinoma 07/2007 - 12/2004
2	Disease Progression 01/2007 - 09/2002
2	Adenocarcinoma 12/2005 - 04/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2003 - 09/2002
1	Myocarditis (Carditis) 01/2018
1	Body Weight (Weight, Body) 01/2015
1	Squamous Cell Carcinoma of Head and Neck 12/2011
1	Agranulocytosis (Granulocytopenia) 10/2008
1	Fever (Fevers) 08/2008
1	Lymphoma (Lymphomas) 07/2008
1	Lung Neoplasms (Lung Cancer) 05/2007
1	Multiple Myeloma 10/2006
1	Sepsis (Septicemia) 06/2006
1	Abdominal Pain (Pain, Abdominal) 05/2006
1	Constipation 05/2006
1	Ileus 05/2006

Drug/Important Bio-Agent (IBA)

10	Irinotecan (Camptosar)FDA LinkGeneric 01/2015 - 06/2003
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2012 - 06/2003
6	Pharmaceutical PreparationsIBA 12/2018 - 02/2005
6	Leucovorin (Folinic Acid)FDA Link 06/2012 - 12/2002
6	Fluorouracil (Carac)FDA LinkGeneric 06/2012 - 12/2002
6	ErbB Receptors (EGF Receptor)IBA 12/2011 - 09/2002
4	Cetuximab (Erbitux)FDA Link 12/2011 - 06/2004
4	DNA (Deoxyribonucleic Acid)IBA 06/2011 - 01/2004
4	Biological ProductsIBA 01/2010 - 04/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2006 - 04/2003
3	Capecitabine (Xeloda)FDA Link 02/2012 - 12/2002
3	Tyrosine Kinase InhibitorsIBA 04/2006 - 09/2002
3	Gefitinib (Iressa)FDA Link 12/2005 - 09/2002
2	thiamine triphosphorate (TTP)IBA 01/2022 - 06/2003
2	afliberceptIBA 10/2012 - 01/2010
2	Cytotoxins (Cytolysins)IBA 12/2011 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 12/2011 - 03/2008
2	1,1'- ((propane- 1,3- diyl)dioxy)bis(7- methoxy- 2- methylidene- 1,2,3,10,11,11a- hexahydro- 5H- pyrrolo(2,1- c)(1,4)benzodiazepin- 5,11- dione)IBA 06/2011 - 01/2008
2	Gemcitabine FDA Link 08/2009 - 10/2006
2	Cisplatin (Platino)FDA LinkGeneric 12/2008 - 04/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2008 - 03/2008
2	von Willebrand FactorIBA 03/2008 - 05/2007
1	Immune Checkpoint InhibitorsIBA 01/2018
1	TubulinIBA 02/2012
1	cevipabulinIBA 02/2012
1	Monoclonal AntibodiesIBA 12/2011
1	Insulin-Like PeptidesIBA 12/2011
1	Celecoxib (Celebrex)FDA Link 12/2011
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 12/2011
1	ganitumabIBA 12/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011
1	Insulin (Novolin)FDA Link 12/2011
1	Methotrexate (Mexate)FDA LinkGeneric 12/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	SR 271425IBA 02/2009
1	thioxanthoneIBA 02/2009
1	Bevacizumab (Avastin)FDA Link 01/2009
1	cediranib (AZD2171)IBA 01/2009
1	Thymidylate SynthaseIBA 12/2008
1	((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA 12/2008
1	Biomarkers (Surrogate Marker)IBA 11/2008
1	Caspase 3 (Caspase-3)IBA 11/2008
1	Epidermal Growth Factor (EGF)IBA 11/2008
1	alovudineIBA 11/2008
1	Epirubicin (Ellence)FDA LinkGeneric 10/2008
1	Pemetrexed (MTA)FDA Link 08/2008
1	Histone Deacetylase InhibitorsIBA 07/2008
1	entinostat (MS 275)IBA 07/2008
1	XELOXIBA 05/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2008
1	Platelet Factor 4IBA 03/2008
1	InterleukinsIBA 03/2008
1	Parathyroid Hormone-Related ProteinIBA 03/2008
1	Transforming Growth Factor alpha (TGF-alpha)IBA 02/2008
1	AmphiregulinIBA 02/2008
1	matrigelIBA 05/2007
1	Histones (Histone)IBA 05/2007
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2007
1	veliparibIBA 05/2007
1	DeoxyribonucleotidesIBA 05/2007
1	TransferasesIBA 05/2007
1	BilirubinIBA 06/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2006
1	Alanine Transaminase (SGPT)IBA 06/2006
1	ABT751IBA 05/2006
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2006
1	Semaxinib (SU5416)IBA 04/2006

Therapy/Procedure

14	Therapeutics 01/2022 - 09/2002
7	Drug Therapy (Chemotherapy) 12/2011 - 12/2002
2	Aftercare (After-Treatment) 12/2011 - 04/2006
1	Precision Medicine 12/2018
1	Catheters 07/2007
1	Continuity of Patient Care 01/2007
1	Oral Administration 05/2006